Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023)
Elicio Therapeutics' (ELTX) quarterly Asset Utilization Ratio came in at 0.02 in Q1 2023, down 93.91% YoY from 0.33 in Q1 2022, and down 63.01% on a QoQ basis from 0.05 in Q4 2022.
Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023) Analysis & Trends
Elicio Therapeutics (ELTX) has 3 years of Asset Utilization Ratio data on file, last reported at 0.02 in Q1 2023.
- Quarterly Asset Utilization Ratio fell 93.91% year-over-year to 0.02 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.02 (down 93.91% YoY) and the FY2022 annual result came in at 0.04, down 90.19% from the prior year.
- Asset Utilization Ratio slipped to 0.02 in Q1 2023, from 0.05 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q3 2022 to a low of 0.02 in Q2 2021.
- A 3-year average of 0.17 and a median of 0.05 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 2251.97% — and 2023, when it plunged 93.91%.
- Tracing ELTX's Asset Utilization Ratio over 3 years: stood at 0.27 in 2021, then plunged by 80.02% to 0.05 in 2022, then tumbled by 63.01% to 0.02 in 2023.
- The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2023), 0.05 (Q4 2022), and 0.43 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Elicio Therapeutics | 59.08 Mn | 35.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.27 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | 0.03 |